Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease

Journal of Interferon and Cytokine Research

Volumn 19, Issue 7, 1999, Pages 757-760

  Heits, Frank ^a   Stahl, Maren ^a   Ludwig, Diether ^a   Stange, Eduard F ^a   Jelkmann, Wolfgang ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; THROMBOPOIETIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; FEMALE; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOSIS;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-6; MALE; MIDDLE AGED; THROMBOCYTOSIS; THROMBOPOIETIN;

EID: 0032807379     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313604     Document Type: Article

References (34)

1. HARRIES, A.D., FITZSIMONS, E., FIFIELD, R., DEW, M.J., and RHODES, J. (1983). Platelet count: a simple measure of activity in Crohn's disease. Br. Med. J. 286, 1476.
2. VAN WERSCH, J.W.J., HOLBEN, P., and RIJKEN, J. (1990). Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease. J. Clin. Chem. Clin. Biochem. 28, 515-517.
3. WEBBERLEY, M.J., HART, M.T., and MELIKIAN, V. (1993). Thromboembolism in inflammatory bowel disease: role of platelets. Gut 34, 247-251.
4. TALBOT, R.W., HEPPEL, J., DOZOIS, R.R., and BEART, R.W. (1986). Vascular complications of inflammatory bowel disease. Mayo Clin. Proc. 61, 140-145.
5. HUDSON, M., CHITOLIE, A., HUTTON, R.A., SMITH, M.S.H., POUNDER, R.E., and WAKEFIELD, A.J. (1996). Thrombotic vascular risk factors in inflammatory bowel disease. Gut 38, 733-737.
6. SOUTO, J.C., MARTINEZ, E., ROCA, M., MATEO, J., PUJOL, J., GONZÁLEZ, D., and FONTCUBERTA, J. (1995). Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig. Dis. Sci. 40, 1883-1889.
7. JACKSON, L.M., O'GORMAN, P.J., O'CONNELL, J., CRONIN, C.C., COTTER, K.P., and SHANAHAN, F. (1997). Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. Q. J. Med. 90, 183-188.
8. COHEN-SOLAL, K., DEBILI, N., VAINCHENKER, W., and WENDLING, F. (1997). Thrombopoietin (MpI-ligand) and the regulation of platelet production. Thromb. Haemost. 78, 37-41.
9. EATON, D.L., and DE SAUVAGE, F.J. (1997). Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp. Hematol. 25, 1-7.
10. KAUSHANSKY, K. (1997). Thrombopoietin: understanding and manipulating platelet production. Annu. Rev. Med. 48, 1-11.
11. GORDON, M.S., and HOFFMAN, R. (1992). Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. Blood 80, 302-307.
12. NAVARRO, S., DEBILI, N., LE COUEDIC, J.-P., KLEIN, B., BRETON-GORIUS, J., DOLY, J., and VAINCHENKER, W. (1991). Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. Blood 77, 461-471.
13. BAATOUT, S. (1996). Interleukin-6 and megakaryocytopoiesis: an update. Ann. Hematol. 73, 157-162.
14. BEST, W.R., BECKTEL, J.M., SINGLETON, J.W., and KERN, F. (1976). Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70, 439-444.
15. RACHMILEWITZ, D. (1989). Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br. Med. J. 298, 82-86.
16. SUNGARAN, R., MARKOVIC, B., and CHONG, B.H. (1997). Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 89, 101-107.
17. FIELDER, P.J., GURNEY, A.L., STEFANICH, E., MARIAN, M. MOORE, M.W., CARVER-MOORE, K., and DE SAUVAGE, F.J. (1996). Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 87, 2154-2161.
18. COHEN-SOLAL, K., VILLEVAL, J.-L, TITEUX, M., LOK, S., VAINCHENKER, W., and WENDLING, F. (1996). Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 88, 2578-2584.
19. STOFFEL, R., WIESTNER, A., and SKODA, R.C. (1996). Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87, 567-573.
20. NAGATA, Y., SHOZAKI, Y., NAGAHISA, H., NAGASAWA, T., ABE, T., and TODOKORO, K. (1997). Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb. Haemost. 77, 808-814.
21. MARTIN, T.G., III, SOMBERG, K.A., MENG, Y.G., COHEN, R.L., HEID, C.A., DE SAUVAGE, F.J., and SHUMAN, M.A. (1997). Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann. Intern. Med. 127, 285-288.
22. PITCHER, L., TAYLOR, K., NICHOL, J., SELSI, D., RODWELL, R., MARTY, J., TAYLOR, D., WRIGHT, S., MOORE, D., KELLY, C., and RENTOUL, A. (1997). Thrombopoietin measurement in thrombocytosis: dysregulation and lack of feedback inhibition in essential thrombocythaemia. Br. J. Haematol. 99, 929-932.
23. FOLMAN, C.C., VON DEM BORNE, A.E.G.K., RENSINK, I.HJ.A.M., GERRITSEN, W., VAN DER SCHOOT, C.E., DE HAAS, M., and AARDEN, L. (1997). Sensitive measurement of thrombopoielin by a monoclonal antibody based sandwich enzymelinked immunosorbent assay. Thromb. Haemost. 78, 1262-1267.
24. CERUTTI, A., CUSTODI, P., DURANTI, M., NORIS, P., and BALDUINI, C.L. (1997). Thrombopoietin levels in patients with primary and reactive thrombocytosis. Br. J. Haematol. 99, 281-284.
25. NICHOL, J.L., HOKOM, M.M., HORNKOHL, A., SHERIDAN, W.P., OHASHI, H., KATO, T., LI, Y.S., HARTLEY, T.D., CHOI, E., BOGENBERGER, J., SKRINE, J.D., KNUDTEN, A., CHEN, J., TRAIL, G., SLEEMAN, L., COLE, S., GRAMPP, G., and HUNT, P. (1995). Megakaryocyte growth and development factor. J. Clin. Invest. 95, 2973-2978.
26. EMMONS, R.V.B., REID, D.M., COHEN, R.L., MENG, G., YOUNG, N.S., DUNBAR, C.E., and SHULMAN, N.R. (1996). Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87, 4068-4071.
27. MARSH, J.C.W., GIBSON, P.M., PRUE, R.L., BOWEN, A., DUNN, V.T., HORNKOHL, A.C., NICHOL, J.L., and GORDONSMITH, E.C. (1996). Serum thrombopoietin levels in patients with aplastic anaemia. Br. J. Haematol. 95, 605-610.
28. HEITS, F., KATSCHINSKI, D.M., WILMSEN, U., WIEDEMANN, G.J., and JELKMANN, W. (1997). Serum thrombopoietin and interleukin 6 concentrations in tumour patients and response to chemotherapy-incuded thrombocytopenia. Eur. J. Haematol. 59, 53-58.
29. HOBISCH-HAGEN, P., SCHOBERSBERGER, W., LUZ, G., INNERHOFER, P., and JELKMANN, W. (1998). Circulating immunoreactive thrombopoietin increases rapidly after normovolemic hemodilution. Thromb. Haemost. 80, 718-719.
30. WANG, J.C., CHEN, C., NOVETSKY, A.D., LICHTER, S.M., AHMED, F., and FRIEDBERG, N.M. (1998). Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis. Am. J. Med. 104, 451-455.
31. BROUDY, V.C., LIN, N.L., SABATH, D.F., PAPAYANNOPOULOU, T., and KAUSHANSKY, K. (1997). Human platelets display high-affinity receptors for thrombopoietin. Blood 89, 1896-1904.
32. SATO, T., FUSE, A., NIIMI, H., FIELDER, P.J., and AVRAHAM, H. (1998). Binding and regulation of thrombopoietin to human megakaryocytes. Br. J. Haematol. 100, 704-711.
33. HORIKAWA, Y., MATSUMURA, I., HASHIMOTO, K., SHIRAGA, M., KOSUGI, S., TADOKORO, S., KATO, T., MIYAZAKI, H., TOMIYAMA, Y., KURATA, Y., MATSUZAWA, Y., and KANAKURA, Y. (1997). Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood 90, 4031-4038.
34. JELKMANN, W., and HARTMANN, E. (1998). Effects of proinflammatory cytokines on the production of thrombopoietin. Pflügers Arch. Eur. J. Physiol. 435 (Suppl. 6), R199.